ImmuPharma PLC
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom. Show More...
-
Website https://www.immupharma.co.uk
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.66 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share GBP -0.02 -0.04 -0.05 -0.05 -0.03 -0.04 -0.05 -0.05 -0.05 -0.04 -0.04 Dividends GBP Payout Ratio % * Shares Mil 81.0 82.0 82.0 82.0 84.0 89.0 117.0 131.0 139.0 153.0 153.0 Book Value Per Share * GBP 0.2 0.18 0.1 0.09 0.04 0.04 0.05 0.05 0.07 0.04 0.03 Free Cash Flow Per Share * GBP -0.09 -0.07 -0.04 -0.04 -0.06 -0.03 -0.07 -0.04 -0.03 -0.03 Return on Assets % -9.38 -21.08 -31.01 -41.65 -40.22 -75.79 -107.31 -106.13 -105.4 -84.7 -84.7 Financial Leverage (Average) 1.1 1.14 1.25 1.33 1.24 1.9 1.21 1.4 1.14 1.1 1.1 Return on Equity % -11.62 -23.56 -36.74 -53.39 -51.7 -105.4 -147.14 -136.47 -128.72 -95.0 -95.0 Return on Invested Capital % -11.25 -22.55 -34.16 -47.77 -46.11 -90.49 -132.38 -127.69 -124.61 -93.94 -93.94 Interest Coverage -940.98 -234.31 Current Ratio 20.65 14.26 9.27 6.3 6.2 1.94 6.32 3.87 5.94 6.73 6.73 Quick Ratio 20.62 14.23 8.92 5.52 5.63 0.9 2.09 2.49 5.03 2.67 2.67 Debt/Equity 0.05 0.07 0.12 0.14 0.07 0.17 0.04 0.03